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The initiation of HIV-1 reverse transcription utilizes a cellular tRNALys,3 as a primer. The 3′ terminal 18-nucleotides of the cellular tRNALys,3
are complementary to a region on the viral genome, designated as the primer binding site (PBS). Previous studies have shown that forcing HIV-1
to utilize alternative tRNA primers through alteration of the PBS results in viruses that revert to utilize tRNALys,3 following in vitro replication. In
some instances though, HIV-1 has been shown to select alternative tRNAs for initiation of reverse transcription if additional mutations upstream in
the U5 region (A-loop) were made to be complementary to these alternative tRNAs. Recently, an HIV-1 has been described in which the U5 region
distinct from the A-loop, designated as the primer activation site (PAS), was mutated in conjunction with the PBS to force the virus to use
tRNALys1,2 as a primer. An additional mutation in reverse transcriptase (RT), G490E, was found to facilitate the forced use of tRNALys1,2 as the
primer. In the current study, we have investigated the impact of the G490E mutation in RT on the selection and use of alternative primers by HIV-
1. Viruses were first constructed in which the PBS and A-loop region were made complementary to tRNATrp. Previous studies from our laboratory
have shown that these viruses are unstable and mutate to select tRNAMet or tRNALys1,2. Analysis of the replication of viruses with the U5 and PBS
complementary to tRNATrp with or without the G490E mutation revealed no significant differences with respect to infectivity and viral growth in
SupT1 or peripheral blood mononuclear cells (PBMC). In addition, the presence of the G490E mutation did not influence the capacity of this virus
to revert to utilize tRNAMet as the primer for initiation of reverse transcription. In a previous study, we have described an HIV-1 that has been
forced to utilize tRNALys1,2 through mutations in the A-loop and PBS. The G490E RT mutation in this virus did not impact on the virus infectivity
or growth in SupT1 or PBMC. We did not find a significant fitness advantage to viruses in which the A-loop and PBS were made complementary
to tRNALys1,2 that also contained the G490E mutation in RT. The results of these studies then establish that HIV-1 can be forced to use alternative
primers through mutations in the U5 (PAS or A-loop) for certain tRNAs. Furthermore, for mutations in the A-loop and PBS, the RT does not play
an important role in dictating the selection of the alternative primers to be used for initiation of reverse transcription.
© 2006 Elsevier Inc. All rights reserved.Keywords: tRNA; Reverse transcriptase; HIV-1; Primer binding siteIntroduction
Reverse transcription of the retroviral RNA genome into a
DNA intermediate is an essential step in virus replication.
Initiation of reverse transcription occurs near the 5′ end of the
viral genome at a site designated as the primer binding site
(PBS) (Panet and Berliner, 1978; Peters and Dahlberg, 1979;⁎ Corresponding author. University of Alabama at Birmingham, Department
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doi:10.1016/j.virol.2006.04.019Temin, 1981). The PBS is complementary to the 3′ terminal 18-
nucleotides of the cellular tRNA that is used as the primer. The
tRNA that is selected from the intracellular milieu for use as a
reverse transcription primer is highly conserved amongst
different retroviruses (Mak et al., 1997; Marquet et al., 1995).
For example, human immunodeficiency virus (HIV-1) exclu-
sively uses tRNALys,3 for initiation of reverse transcription. The
mechanism of how retroviruses select particular tRNAs
probably involves multiple mechanisms. Previous studies with
HIV-1 have found that the Gag and Gag-Pol proteins are
assembled into virus-like particles which are enriched for
tRNALys1,2 and tRNALys,3 (Kohorchid et al., 2000; Mak et al.,
1994). Recent studies have shown that lysl tRNA synthetase is
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chaperone tRNALys1,2,3 into virions (Cen et al., 2002;
Javanbakht et al., 2003; Jiang et al., 1994).
Although tRNALys1,2,3 are enriched in HIV virions, previous
studies have shown that HIV-1 has the capacity to select and use
alternative (non-tRNALys,3) primers for replication (Das et al.,
1995; Li et al., 1994; Wakefield et al., 1995). In early studies, it
was found that alteration of the PBS to be complementary to a
variety of primers resulted in the virus able to select and use
these primers for a limited time of in vitro culture. Eventually,
all of these viruses reverted back to utilize tRNALys,3. Follow-
up studies found that additional mutations upstream of the PBS
in a region designated as the A-loop allowed the virus to stably
utilize some but not all alternative tRNAs that were examined
(Kang and Morrow, 1999; Kang et al., 1997, 1999; Wakefield et
al., 1996; Zhang et al., 1998). As a consequence of forcing HIV-
1 to utilize these alternative tRNAs, the resultant viruses all
exhibited a reduced growth as compared to the wild-type virus.
Thus, even under conditions designed to promote the use of
alternative tRNAs, including tRNALys1,2 which is enriched in
virions, HIV-1 has evolved towards a preference for the
selection and use of tRNALys,3 as the primer for high-level
replication.
In a previous study, we reported on the construction and
characterization of an HIV-1 which stably utilizes tRNALys1,2
rather than tRNALys,3 as the primer for reverse transcription
(Kang and Morrow, 1999; Kang et al., 1999). This virus was
initially derived from a culture of HIV-1 in which the PBS and
A-loop region had been mutated to be complementary to
tRNAMet (Kang et al., 1997). Viruses which use tRNAMet were
identified from cultures in which the PBS and A-loop had been
mutated to correspond to tRNATrp (Kang et al., 1996). Thus, the
parent virus for subsequent viruses that use tRNALys1,2 or
tRNAMet was derived from the in vitro culture of viruses in
which the PBS and A-loop were mutated to be complementary
to tRNATrp (Kang and Morrow, 1999; Kang et al., 1996, 1997,
1999). The results from these studies highlight some of the
complex evolution that can occur following modification of the
PBS. In a recent study, a second HIV-1 virus that utilizes
tRNALys1,2 for initiation of reverse transcription was described
(Abbink et al., 2004). For this study, the authors again made the
PBS complementary to tRNALys1,2 but mutated a region
upstream of the A-loop designated as the primer activation
signal (PAS) to be complementary to tRNALys1,2. The PAS is
complementary to the T φ C arm of tRNALys,3. The PAS does
not contribute to tRNA-PBS annealing but is essential for
initiation of tRNA primed reverse transcription. In vitro studies
have demonstrated that HIV-1 primer usage can be switched
from tRNALys,3 to tRNALys1,2 by the use of RNA templates
containing the PAS and PBS double mutations (Beerens and
Berkhout, 2002). Analysis of HIV-1 with PAS and PBS
complementary to tRNALys1,2 revealed that following exten-
sive long-term in vitro culture HIV-1 could stably utilizes
tRNALys1,2 for replication. An additional mutation in the virus
was found within the RT gene of HIV, a G490E mutation in
the RT (RNase H) gene facilitated the virus replication and use
of tRNALys1,2 as the primer for replication.In a current study, we wanted to determine whether the
G490E mutation in RT would effect the selection of tRNA
primers in HIV-1 in which the A-loop and PBS had been
mutated to correspond to alternative tRNAs. Our first study
utilized an HIV-1 in which the PBS and A-loop were mutated to
be complementary to tRNATrp, since our previous studies have
suggested that this virus would naturally evolve to utilize
tRNAMet and possibly tRNALys1,2 following in vitro culture
(Kang et al., 1996, 1997). We also determined the effect of the
G490E mutation in RT on the replication of HIV-1 in which we
have engineered to utilize tRNALys1,2 through simultaneous
mutations in the A-loop and PBS (Kang et al., 1999). The
results of our studies demonstrate that for viruses which contain
A-loop and PBS mutations, the G490E mutation in RT does not
substantially impact on selection of primer tRNA and virus
replication. The results are discussed with respect to the
importance of the U5 region in the selection of the tRNA primer
used for HIV-1 replication.
Results
Effect of G490E mutation in RT on capacity of HIV-1 to select
an alternative primer for replication
In a previous study, we described construction and
characterization of HIV-1 proviral genomes in which the PBS
and A-loop region were mutated to be complementary to
tRNATrp (Kang et al., 1996). These proviral constructs used the
HXB2 backbone, and the virus replication was analyzed in
SupT1 cells. We found that viruses in which only the PBS was
mutated to be complementary to the 3′ terminal nucleotides of
tRNATrp reverted to utilize tRNALys,3 following short-term in
vitro replication in SupT1 cells. In contrast, viruses which
contained both the A-loop and PBS complementary to tRNATrp
were unstable but reverted to utilize tRNAMet following in vitro
culture. Subsequent characterization of the virus which uses
tRNAMet revealed the potential to revert to use tRNALys1,2 then
back to tRNALys,3 (Kang et al., 1997). In a recent study, we have
further characterized the replication of the virus which utilizes
tRNAMet (Moore-Rigdon et al., 2005). In this case, we found
that viruses derived from NL-4 in which the PBS alone was
altered to be complementary to tRNAMet were stable upon
replication in either SupT1 or PBMC. Given the interesting and
diverse phenotypes of the viruses which use tRNATrp, we
wanted to ascertain the effects of the G490E mutation in RT for
effects that it would have on the growth of these viruses and
potential to revert and utilize an alternative tRNA. Viruses were
constructed using the NL-4 provirus in which the PBS and A-
loop were mutated to be complementary to the 3′ terminal
nucleotides and anticodon region respectively of tRNATrp. We
also engineered the G490E mutation into the RT gene of these
viruses and a wild-type control virus (Fig. 1A).
We first analyzed the infectivity of these viruses following
transfection into 293 T cells. Virus supernatant was assayed for
the capacity to infect the JC53BL indicator cell line and
infectivity determined as previously described (Moore-Rigdon
et al., 2005). The infectivity obtained from transfection of wild-
Fig. 1. Characterization of HIV-1 with PBS complementary to tRNATrp. (A) Sequences of HIV-1 and U5-PBS complementary to tRNATrp and G490E mutation in RT.
The proviral backbone NL-4 (NL-4-WT) was used for the construction genomes. The sequences in bold (GGAAAAT) correspond to the A-loop region that is
complementary to the anticodon region of tRNALys,3. The 18-nucleotide (bold sequence) 3′ to the A-loop region is the primer binding site (PBS), which is
complementary to tRNALys,3 for NL-4-WTand NL-4-WT (G490E). These viruses differ by a mutation in the RT gene (G to A nucleotide 4018 of the NL-4 sequence),
which results in a G490E mutation. Proviral constructs in which the PBS and A-loop region/PBS were mutated to correspond to tRNATrp were taken from a previous
study (Kang et al., 1996). The region complementary to the anticodon region of tRNATrp is denoted in bold (TCTGGAGT) and the PBS downstream of this region also
noted in bold (NL-4-Trp; NL-4-Trp-AC). The G490E mutation was engineered into proviruses in which the PBS and PBS with A-loop were mutated to be
complementary to tRNATrp resulting in the notation G490E (NL-4-Trp (G490E); NL-4-Trp-AC (G490E)). (B) Infectivity of wild-type and mutant viruses from
transfection of 293T cells. Proviral DNAwas transfected into 293T cells, and the amount of infectious virus in the supernatant was determined using the JC53 assay
(Derdeyn et al., 2000). The infectivity represents the amounts of infectious units divided by the levels of p24 antigen. The level of infectivity obtained from the wild-
type virus (NL-4-WT) was set at 100%. The amounts of infectious virus obtained from the wild-type virus containing the G490E mutation in RT as well as the viruses
with a PBS and PBS A-loop complementary to tRNATrp containing the G490E mutation were also determined. The levels of p24 were determined by ELISA. Standard
deviations are represented by the error bars.
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mutants compared to this level (Fig. 1B). The G490E mutation
in the wild-type virus reduced the infectivity of the wild-type
virus by approximately 60% in this assay. Viruses in which the
PBS alone or PBS plus A-loop were mutated to be
complementary to tRNATrp demonstrated a reduced infectivity
compared to the wild type. For the virus with only the PBS
complementary to tRNATrp, we observed an infectivity that was
approximately 10% of that of the wild-type level, while for
viruses with both PBS and A-loop, the infectivity was only 3%
of the wild-type levels. Consistent with the results obtained with
the wild-type virus, the G490E mutation in RT also reduced the
infectivity of the viruses with a PBS complementary to
tRNATrp. In contrast, infectivities of virus with both the PBSand A-loop complementary to tRNATrp had similar infectivities
(albeit very low), as the virus with the wild-type RT.
We next examined the infectivity of these viruses following
continuous culture with SupT1 cells (Fig. 2A). We initiated the
infections with equal amounts of infectious virus and followed
the p24 levels in the cultured supernatant for approximately 35
days. The wild-type virus demonstrated a rise in p24 levels
peaking at approximately day 14 post-initiation of culture.
There were no clear-cut differences between the levels of p24
observed in cultures from the wild-type viruses with or without
the G490E mutation in RT. In contrast, the viruses with the PBS
only altered to be complementary to tRNATrp demonstrated a
delay in replication. By day 14 of culture, viruses with the wild-
type RT began to increase, peaking at day 28 of culture. The
Table 1
DNA sequence of PBS following extended cultures in SupT1 (Day 35)
Input U5-PBS RT
NL-4-Trpa PBS region is complementary
to tRNAMet b
No changec
NL-4-Trp(G490E) PBS region is complementary
to tRNAMet
No change
NL-4-Trp-AC No growthd No growth
NL-4-Trp-AC(G490E) No growthd No growth
a Input proviral DNA.
b The PBS from integrated proviruses complementary to tRNAMet.
c No change in WT or G490E mutation of RT from input.
d This virus did not grow; no PCR product recovered.
Fig. 2. Replication of viruses in SupT1 cells. (A) Infections were initiated in
SupT1 cells as described in the Materials and methods. Virus replication was
monitored by the levels of p24 antigen in the culture supernatants selected at
days following initiation of culture. The key is as follows: solid circles, NL-4-
WT; open circles, NL-4-WT (G490E); open box, NL-4-Trp; closed box, NL-4-
Trp (G490E); X, NL-4-Trp-AC; + NL-4-Trp-AC (G490E). Both proviruses
containing the Trp-AC mutations did not have p24 antigen in the culture
supernatants over the background value obtained from mock transfection. The
data are representative of three independent virus infections. (B) The infectivity
of virus obtained following day 35 of culture in SupT1 was determined using the
JC53 assay. Infectivity represents the infectious units divided by the p24 antigen
obtained from the cultured supernatant at day 35 post-infection as shown from
panel A. Note that the viruses with the anticodon mutation complementary to
Trp did not grow and therefore were not included in this assay. Virus obtained
from NL-4-WT was set at 100%. The levels of NL-4-WT (G490E) and NL-4-
Trp with and without the G490E are presented. Error bars are standard deviation.
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began to increase approximately 7 days after (day 21 of culture),
then increased to a level similar to that of the wild-type viruses
by day 35. In contrast, viruses in which both the PBS and A-
loop were mutated to be complementary to tRNATrp did not
grow in SupT1 under these culture conditions; regardless of
whether the RT was mutated, both viruses did not show any
increase in p24 following long-term in vitro culture.
One of the interesting features of the viruses in which the
PBS is complementary to tRNATrp is the propensity to revert to
utilize tRNAMet or tRNALys,3 (Kang and Morrow, 1999; Kang
et al., 1996). In a previous study, we had identified viruses inwhich both the PBS and A-loop complementary to tRNATrp
resulted in the virus to mutate to utilize tRNAMet. Since only the
viruses with the PBS complementary to tRNATrp grew in SupT1
cells, we analyzed the high molecular weight DNA from these
viruses to determine if the PBS was stable. Analysis of the
cultures derived from day 35 infection in SupT1 cells revealed
that these viruses had reverted to utilize tRNAMet, regardless of
whether or not the RT mutation was present (Table 1).
Consistent then with our previous studies, we found that once
the viruses had reverted to utilize tRNAMet, they grew to levels
in our culture system consistent with that observed for the wild-
type virus. Interestingly, we have analyzed the infectivity of
viruses obtained after day 35 cultured in SupT1 cells (Fig. 2B).
This time, we found that the wild-type virus with the G490E
mutation was approximately 90% as infectious as the wild type
which differs from the infectivity of this virus derived from
transfection of 293 T cells. The reason for this difference is
unclear but could be due to the source of the virus (293 T cells
compared to SupT1 cells). Sequence analysis of the RT gene
confirmed though that the viruses still had maintained the
G490E mutation with no additional RT mutations (data not
shown). In contrast, viruses in which the PBS was comple-
mentary to tRNATrp (initially and following mutation to be
complementary to tRNAMet) grew at approximately 10% the
level of the wild-type virus. Thus, although the assays for p24
production show that the viruses are growing in a similar
fashion as the wild-type virus at day 35, the infectivity is still
relatively low compared to the wild-type virus as measured in
the JC53 assay. Collectively, the results of these studies
establish that the replication of the viruses in which the PBS
was complementary to tRNATrp was not influenced by the
G490E mutation in HIV-1 RT. Furthermore, the propensity to
revert to utilize an alternative tRNA (tRNAMet) or the further
selection to generate a virus that uses tRNALys1,2 was also not
influenced by the RT mutation.
We next examined the infectivity of the viruses in PBMC.
Again, the wild-type viruses with or without the G490E
mutation in RT demonstrated substantial infectivity that peaked
between days 7 and 14 post-initiation of the culture. There were
no differences between the replication of the wild type
containing the RT mutation. In contrast, viruses in which the
PBS was altered to be complementary to tRNATrp did not grow
(or grew very poorly) following 35 days of in vitro culture,
regardless of whether or not the viruses contained the mutation
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not increase over the culture period; similar to what we found
with the viruses which contained both the A-loop and PBS
complementary to tRNATrp, these viruses also did not grow
during this culture period.
The results of these studies suggest then that the mutation in
RT did not effect the replication of the wild-type virus in either
SupT1 cells or PBMC. Furthermore, the replication of viruses in
which the PBS was complementary to tRNATrp alone was
slightly delayed in SupT1 cells as a result of the 490E mutation.
However, regardless of RT mutation, viruses contained both the
anticodon and PBS complementary to tRNATrp were non-
infectious as determined by the infectivity assay from
transfected cell culture supernatants as from analysis of growth
in SupT1 and PBMC cultures.
Effect of G490E mutation in RT on virus replication that uses
tRNALys1,2 for reverse transcription
In a previous study, we have identified and characterized an
HIV-1 in which it utilized tRNALys1,2 rather than tRNALys,3 for
replication (Kang and Morrow, 1999; Kang et al., 1999).Fig. 3. Characterization of HIV-1 with PBS and A-loop complementary to tRNALys1
constructs in which the A-loop and PBS complementary to tRNALys,3 (NL-4-WT) wit
construct NL-4-Lys12-AC in which the A-loop and PBS are complementary to tRN
2005). Mutations in the RT gene (G490E) were constructed into the proviral clone to
and A-loop complementary to tRNALys1,2. The infectivities of wild type and NL-4-Lys
proviral constructs into the 293T cells. The amount of infectious units obtained in the
measured by ELISA. Infectivity for the wild type (IUs/p24) was set at 100%. The valu
which the PBS and A-loop were mutated to be complementary to tRNALys1,2 (NL-4-L
wild type was set at 100%. The bars indicate standard deviation.Interestingly, this virus was identified from the characterization
of the long-term replication of the virus that uses tRNAMet for
replication. We found that viruses could be stabilized to utilize
tRNALys1,2 if additional mutations were made within the A-loop
region to be complementary to the anticodon of tRNALys1,2. A
recent study also characterized an HIV-1 which utilizes
tRNALys1,2 for replication (Abbink et al., 2004). In this case,
additional mutations, made upstream of the A-loop region at a
position identified as the primer activation signal, were required
to be complementary to tRNALys1,2 in order for the virus to
stably utilize this tRNA for replication. During the character-
ization of this virus, the G490E mutation in RT was identified
and postulated to co-operatively help the virus to maintain the
use of tRNALys1,2. Since the G490E mutation in RT did not
impact on the stability or selection of tRNAs with viruses in
which the PBS was altered to be complementary to tRNATrp, we
wanted to determine whether or not this would be specific for
the virus that uses tRNALys1,2 as a result of A-loop modifica-
tions. In these studies, we made use of our previously described
mutant in which both the A-loop and PBS were mutated to be
complementary to tRNALys1,2 (Fig. 3A). This region was cloned
into the NL-4 provirus and the infectivity as well as replication,2. (A) Sequence of HIV-1 with U5-PBS complementary to tRNALys1,2. Proviral
h and without mutations in the RT (G490E) are depicted as in Fig. 1A. A proviral
ALys1,2 (shown in bold) was taken from a previous study (Moore-Rigdon et al.,
give NL-4-Lys12-AC (G490E). (B) Infectivity of wild type and HIV with PBS
12-AC and NL-4-Lys12-AC (G490E) were determined following transfection of
supernatants was determined by the JC53 assay; the levels of p24 antigens were
es for the wild type with the G490E mutation (NL-4-WT (G490E)) and viruses in
ys12-AC) with and without the G490E mutation were determined. The value for
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infectivity of viruses obtained following transfection in 293 T
cells. As presented previously, we found that wild-type viruses,
which contained the G490E mutation in RT, had approximately
40% the infectivity of wild-type viruses. Virus which contained
the A-loop and PBS mutated to be complementary to the
tRNALys1,2 had infectivities that were approximately 10% of
that of the wild-type virus (regardless of whether or not the RT
mutation was present) (Fig. 3B).
We first analyzed the replication of these viruses in SupT1
cells (Fig. 4A). Cultures were initiated with similar amounts of
infectious units, and the amounts of p24 produced in the culture
supernatant were analyzed over a 35-day culture period. As
shown previously for the wild type, the presence or absence of
the G490E mutation in RT did not significantly impact on the
replication of the virus in SupT1 cells. We found a rise in p24Fig. 4. Replication of HIV-1 with U5-PBS complementary to tRNALys1,2
containing the G490E mutation. (A) SupT1 cells were infected with NL-4 wild
type (with and without G490E mutation) and NL-4-Lys12-AC (with and without
G490E mutation). Infection was monitored by assaying levels of p24 antigen in
the culture supernatants at selected days for 35 days. (B) PBMC. Infection of the
NL-4-WT (with and without G490E mutation) and NL-4-Lys12-AC (with and
without G490E mutation) was established in PBMC. Infection was monitored
by levels of p24 antigen in the culture supernatant at selected days for 35 days.
Key to both panels: closed circles, NL-4-WT; open circles, NL-4-WT (G490E);
closed square, NL-4-Lys12-AC; open square, NL-4-Lys12-AC (G490E). The
data presented are representative from three independent infections.production starting at day 7 that peaked by 14 days post-
initiation of culture and was maintained for the 35-day culture
period. Interestingly, similar results were found with viruses in
which the PBS and A-loop were altered to be complementary to
tRNALys1,2. In this case, we noted a slight delay in the
production of p24 in the culture supernatant at day 7 compared
to the wild-type levels, but by day 14, these levels had reached a
peak value that was similar to that for the wild-type virus. There
was no difference with respect to the amounts of p24 produced
in the cultures where viruses contained the 490E mutation in
RT. We next characterized the replication of these viruses in
PBMC (Fig. 4B). Again, for these studies, we initiated the
cultures with similar amounts of IUs and followed the
replication by the presence of p24 in the culture supernatant.
There was no significant difference between the replication of
the wild-type virus with or without the G490E mutation. In
contrast, viruses in which the PBS and anticodon were
complementary to tRNALys1,2 grew poorly in PBMC, reaching
levels approximately 1% of that of the wild-type virus by day 14
and day 21 post-initiation of culture. The levels of p24 were
significantly higher than that of the background levels (or levels
obtained from viruses which contained the PBS complementary
to tRNATrp) indicating that replication had occurred. We next
analyzed the U5-PBS from viruses which were complementary
to tRNALys1,2. Consistent with our previous studies, we found
that these viruses maintained a PBS complementary to
tRNALys1,2 (data not shown). There is no difference between
viruses which contained the G490E mutation and the wild-type
RT. Furthermore, sequence analysis of the RT gene revealed that
the mutation was stable following in vitro culture in PBMC.
Given that the viruses were stable following culture in
PBMC, we wanted to determine if there was a subtle effect of
the G490E mutation that would allow a greater fitness in
culture. For these studies, we initiated cultures with varying
input ratios of wild type to G490E mutated viruses (Table 2). As
a control, we first analyzed the wild-type virus replication using
input ratios of 10:1 (wild type) RT to G490E mutation, 1:1 and
1:10, respectively. In cases where the dominant virus that
initiated cultures was either the wild-type RT or the mutant RT,
we found that these viruses still dominated following 35 days of
culture in PBMC. Thus, at a 10:1 ratio of either virus, there was
no significant advantage of the wild type over the mutant RT.
Initiating cultures with equal amounts of infectious units
followed by analysis of the RT revealed a similar equal
distribution following TA cloning of PCR amplified RT genes
from these cultures at day 35. In this case, 10 of the 18 TA
clones obtained were from the wild-type RT as the remaining
8 were from the G490E mutant. We next compared the fitness of
viruses in which both the A-loop and PBS were complementary
to tRNALys1,2. Using the same strategy for analysis, we found
that again if the dominant virus contained either the wild-type or
mutant RT, we recovered mainly this RT following in vitro
culture of 35 days with the PBMC. Initiating cultures with equal
amounts of virus followed by TA cloning of the amplified RT
genes after 35 days of culture in PBMC revealed a slight
advantage for the RT G490E mutant compared to the wild type
(13 of 19 TA clones, compared to 6 of 19 TA clones). This result
Table 2
Replication competition experiments between HIV with WTor G490E mutation
in RT
Virusa Inputb
RT-WT:RT-G3600A
Samplec Sequencing of
RT Region
NL-4 10 to 1 PCR RT-WT
NL-4 1 to 1 TA cloning 10/18 RT-WT,
8/18 RT-G490E
NL-4 1 to 10 PCR RT-G490E
NL-4-Lys1,2-AC 10 to 1 PCR RT-WT
NL-4-Lys1,2-AC 1 to 1 TA cloning 6/19 RT-WT,
13/19 RT-G490E
NL-4-Lys1,2-AC 1 to 10 PCR RT-G490E
a Virus used in competition (NL-4-WT or NL-4-Lys1,2-AC).
b Starting ratio of virus in infectious units as determined by JC53-BL assay.
c Sample used for DNA sequencing. PCR refers to direct sequencing of PCR
product for high molecular weight DNA. No ambiguities in the RT region
encompassing G490E. TA cloning refers to PCR product cloned into TA vector
and individual colonies sequenced.
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contain the G490E mutation in RT that utilized tRNALys1,2 for
initiation of reverse transcription. However, the dominant effect
for viruses to utilize tRNALys1,2 or other alternative tRNAs
appears to reside in the PBS and U5 region rather than the RT
mutation.
Discussion
In the current study, we have investigated the potential of a
mutation in the HIV-1 RT (G490E) to influence primer
selection. This mutation in RT was previously identified to
facilitate the use of tRNALys1,2 as a primer for HIV-1 reverse
transcription (Abbink et al., 2004). We found that viruses in
which the PBS alone or PBS and A-loop were mutated to be
complementary to tRNATrp were not influenced by the presence
or absence of the G490E mutation in RT. Regardless of whether
the RT mutation was present, the virus with a PBS
complementary to tRNATrp mutated to use tRNAMet. We next
examined the effects of the G490E mutation on the replication
of HIV-1 in which the A-loop and PBS had been altered to be
complementary to tRNALys1,2. Previous studies from our
laboratory had demonstrated that this virus stably maintains a
PBS complementary to tRNALys1,2 (Kang and Morrow, 1999,
Kang et al., 1999). Comparison of the replication of viruses with
and without the G490E mutation revealed no substantial
differences. Thus, while the G490E mutation in RT might
facilitate the replication of HIV-1 with a PBS and upstream
region in the U5 (PAS) complementary to tRNALys1,2, this RT
mutation does not affect the replication of viruses with
mutations in the A-loop region of U5 that facilitate the use of
alternative tRNA primers.
Previous studies from our laboratory and others have used
genetic manipulation of the HIV-1 genome to gain insights
into the mechanism by which HIV-1 selects the primer tRNA
required for HIV-1 replication. We and others have shown that
alteration of the PBS so as to be complementary to alternative
tRNAs results in viruses that utilize these tRNAs for short-
term in vitro replication but rapidly revert back to utilizetRNALys,3 (Das et al., 1995; Jiang et al., 1994; Wakefield et
al., 1995). To stabilize the use of these alternative tRNAs, we
have made additional changes within the U5 region that are
complementary to the anticodon region of certain tRNAs. This
strategy has allowed us to derive HIV-1 which can stably
utilize tRNAMet, tRNALys1,2, tRNAHis and more recently
tRNAGlu (Dupuy et al., 2003; Kang and Morrow, 1999, Kang
et al., 1997, 1999; Wakefield et al., 1996; Zhang et al., 1998).
Not all U5-PBS combinations allow the virus to utilize
alternative tRNAs such that viruses with A-Loop-PBS
combinations complementary to tRNAIle, tRNAPro, and
tRNATrp were not stable and reverted back to utilize tRNALys,3
or in some instances (tRNATrp), alternative tRNAs. In a
previous study, we characterized the virus that utilizes
tRNAHis for replication. From DNA sequence analysis of
integrated proviruses, we found that there were no consistent
mutations in the structural genes (nucleocapsid and RT),
suggesting that mutations did not occur to compensate for the
use of alternative tRNAs (Zhang et al., 1996, 1998). In support
of this, we noted that the virus could rapidly utilize tRNAHis
following mutation of the A-loop and PBS, suggesting that no
additional mutations in structural genes were required. It is
important to note though that these viruses, as well as all of
our viruses which utilize alternative tRNAs for replication, do
not replicate with the same efficiency as the wild-type HIV-1.
Similar to what we have presented in this study, we noted that
for the most part, viruses in which the PBS or PBS and A-loop
had been altered, exhibit approximately 1/10 the infectivity as
that for the wild-type HIV-1. Thus, the recent study by Abbink
et al. was of particular interest because the authors have shown
that HIV-1 can be forced to utilize tRNALys1,2 following
mutations within the PBS and U5 (PAS, not A-loop region)
(Abbink et al., 2004). Characterization of this virus revealed
an additional mutation in the RT gene, G490E, which
facilitated the replication of HIV-1 with a PBS complementary
to tRNALys1,2. The basis of our experiments then was to test
whether or not this mutation in HIV-1 RT could impact on
viruses which utilized other tRNAs (tRNATrp) as well as a
virus in which we had described that utilizes tRNALys1,2 but
contains a mutation within the A-loop rather than the PAS. The
results of our studies clearly show that the G490E mutation
does not substantially effect the replication or the primer
utilization of the viruses in our study that have been
engineered to be complementary to tRNATrp or tRNALys1,2.
Interestingly, the virus which was engineered to be comple-
mentary to tRNATrp has, in previous studies, been shown to
mutate in culture to utilize tRNAMet or tRNALys1,2 under the
appropriate conditions (Kang et al., 1996). If the HIV-1 RT
G490E mutation facilitated the use of tRNALys1,2, we would
have expected the virus to utilize tRNATrp to mutate directly to
utilize tRNALys1,2 or during the culture period revert to
selectively utilize tRNALys1,2. Clearly, this was not observed in
our studies. Thus, we believe that the G490E mutation in RT,
while it can contribute some to the increased HIV-1 replication
for the virus with the PBS complementary to tRNALys1,2,
could only be manifested in the viral competition experiments
between isogenic genomes that only contain the G490E
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preference of viruses that were engineered to utilize tRNATrp
to select tRNALys1,2.
The results of our studies and Abbink et al. support the
concept that the U5-PBS region is the major determinant for the
selection of the tRNA primer, and that HIV-1 can be forced to
utilize alternative primers through mutations in the U5 and PBS.
Alteration of the PBS with either the A-loop or PAS can result in
HIV-1 stably utilizing tRNALys1,2 for replication. However, in
each case, the virus does not grow as well as the wild-type virus.
This result is interesting when in the context that tRNALys1,2 is
incorporated into the HIV-1 genome at levels similar to and
many times greater than that for the preferred tRNA primer,
tRNALys,3 (Jiang et al., 1993). If primer selection relied merely
on just the position of the tRNA primer in close proximity to the
PBS, one would suspect that alteration of the PBS and A-loop/
PAS to be complementary to tRNALys1,2 should result in a virus
that has replication characteristics similar to that of the wild-
type virus. Indeed, slight mutations in RT to accommodate the
differences between tRNALys,3 and tRNALys1,2 (such as the
G490E mutation) would be expected to occur when the virus
was forced to utilize tRNALys1,2 that would lead to viruses with
replication characteristics similar to that of the wild-type virus.
The fact that all viruses in which the PBS has been altered to be
complementary to alternative tRNAs have replication charac-
teristics that differ from the wild-type virus suggests that primer
selection might be coupled with other elements of the viral
replication cycle. Previous studies from this laboratory have
suggested that primer selection is coupled with translation in
that tRNAs which are aminoacylated are most effectively
selected as primers for HIV-1 reverse transcription (Kelly and
Morrow, 2003; Kelly et al., 2003). These results lead to the
suggestion that HIV-1 primer selection could possibly occur in
conjunction with HIV-1 translation and/or the switch from
translation to encapsidation of the viral genomic RNA. With
respect to this issue, it is possible that the mutations required in
the U5 region (PAS and/or A-loop) act in a similar fashion to
reduce the replication of HIV-1 to facilitate the selection of
alternative tRNAs. Consequently, this implies that HIV-1
selects the tRNA primer from a pool of intracellular tRNAs
that is highly enriched with tRNALys,3 to facilitate high-level
replication. Alteration of the U5-PBS region results in a virus
that replicates slower, possibly because the virus required
tRNAs that are not dominant in the intracellular pool (e.g.,
tRNALys1,2). Additional experiments with mutations in the U5
region (PAS and A-loop) would be required to substantiate this
possibility and further define the mechanism of primer
selection.
Materials and methods
Tissue culture
The SupT1 cells were maintained in RPMI 1640, supple-
mented with 15% fetal bovine serum (FBS) and 1% antibiotic–
antimycotic. The 293 T cells were maintained in DMEM plus
10% FBS and 1% antibiotic–antimycotic. Human peripheralblood mononuclear cells (PBMC) were collected, stimulated
using rIL-2 and phytohemagglutinin (PHA) (Sigma, St. Louis,
MO), and maintained as described previously (Dupuy et al.,
2003). All the cell culture media were from Cellgro by
Mediatech, Herndon, VA.
Construction of NL4-3 proviruses containing PBS and RT
mutations
The NL-4-Lys1,2-AC mutant was described as previously
(Moore-Rigdon et al., 2005). For the construction of NL-4-Trp
and NL-4-Trp-AC mutants, proviral clones pHXB2-Trp and
Trp-AC (Kang et al., 1996) were used to provide the U5-PBS
region. After digestion with HpaI and BssHII restriction
enzymes, an 868-bp fragment that contained the 5′ LTR, PBS,
and leader region gag of HXB2 was separated and cloned into
the NL4-3 HIV-1 proviral plasmid using HpaI and BssHII
restriction sites. All resulting NL4-3 constructs were verified by
DNA sequencing.
To construct the RT mutation, the RT region of NL-4 PBS
mutants was cloned into Litmus28 vector after digestion by
AgeI and EcoRI. QuickChange site-directed mutagenesis of RT
region was carried out on Litmus28 using PCR methods;
template DNA (400 ng), pfu Turbo DNA polymerase
(Stratagene), Turbo DNA polymerase buffer, and dNTPs were
used for PCR as described by the manufacturer, PCR was
performed by three cycling (95 °C for 30 s, 55 °C for 1 min, and
68 °C for 5 min) for 16 cycles, then elongation for 10 min at
68 °C. The synthetic oligonucleotides primers for mutant RT
were 5′-TCTAGCTTTGCAGGATTCGGAATTAGAAG-
TAAACATAGTGAC-3′ (sense) and 5′-GTCACTATGTT-
TACTTCTAATTCCGAATCCTGCAAAGCTAGA-3′ (anti-
sense). The underlined nucleotides are the ones changed from
the wild type. After PCR the methylated parental DNA template
was digested with DpnI for 1 h at 37 °C, and then the reaction
mixture containing DNA was transformed into DH5-α cells.
Colonies were selected on LB agar plates with ampicillin
(100 μg/ml). The mutations were confirmed by DNA
sequencing. Finally, the segment of RT region was separated
from Litmus28 after digestion by AgeI and EcoRI and ligated to
NL-4 that had been digested by AgeI and EcoRI.
DNA transfections
Transfections were performed according to the protocol for
the Fugene 6 Transfection Reagent (Roche Molecular
Biochemicals, Indianapolis, IN). Briefly, 2 μg of proviral
plasmid DNA and 6 μl Fugene reagent were added to 200 μl
of DMEM (no FBS). This mixture was incubated at room
temperature for approximately 30 min then added drop-wise
to one well of a 6-well plate containing 50% confluent 293 T
cells in DMEM with 10% FBS. The transfections were
incubated overnight at 37 °C, then the medium was replaced
with fresh DMEM containing 10% FBS. After 48 h, all
supernatants were collected and filtered through 0.45-μm-
pore-size syringe filters and stored at −80 °C. Supernatants
from transfected cells were assayed for HIV-1 p24 antigen by
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determined by JC53BL assay as described previously (Moore-
Rigdon et al., 2005).
Infection of SupT1 and PBMC
Infections were performed by inoculating 1 × 106 SupT1
cells or 5 × 106 PHA-stimulated PBMC with viral supernatant
containing 1000 IU of virus. Following incubation for 2 h at
37 °C, with shaking every 30 min, virus/PBMC mixtures were
transferred to 25-cm2 tissue culture flasks, and the final volumes
were adjusted to 10 ml with RPMI 1640, containing 15% FBS.
PBMC were also cultured with 30 U/ml rIL-2.
Every 3 days, the infected SupT1 cells were passaged 1:5. For
PBMC cultures, half of medium was replaced every 3 days
without removing PBMC. Every 7 days, 1 ml of cell suspension
was removed for SupT1 and PBMC cultures and centrifuged at
24,000 × g for 2 min. Supernatant was separated from the cell
pellets and stored at −80 °C for further analysis by p24 ELISA
and JC53BL infectivity assays. Cell pellets were also stored at
−80 °C for isolation of high molecular weight DNA. Once the
SupT1 cell culture was cleared of cells, 1 × 106 SupT1 cells were
added to the culture every 3 days. Every 14 days, an additional
5 × 106 PHA-stimulated PBMC were added to PBMC culture.
Dual infection assay
Virus with wild-type RT or mutant RT was mixed with the
ratio of wild-type RT to mutant RT as follows: A: 10 IU to 1000
IU; B: 1000 IU to 1000 IU; and C: 1000 IU to 10 IU. SupT1 and
PBMC cells were infected by different mixtures as described in
the previous section. At day 35, the cell pellets were collected
for PCR and DNA sequence analysis.
Subcloning of PCR products and DNA sequencing
High molecular weight DNA was extracted from infected
SupT1 or PBMC cell pellets following the instructions ofWizard
Genomic DNA Isolation Kit (Promega). The regions of U5-PBS
and RTwere amplified by PCR from the high molecular weight
DNA. The primers used to amplify U5-PBS regions are 5′-
CGGAATTCTCTCCTTCTAGCCTCCGCTAGTC-3′ and 5′-
CCTTGAGCATGCGATCTACCACACACAAGGC-3′. The
primers used to amplify RT regions are 5′-GACAGAG-
TATTGGCAAGCCACCTGGAT-3 ′ and 5 ′ -GCCA-
TATTCGTGGGCTACAGTCTACTT-3′. The resulting PCR
products were gel purified and ligated to the pGEM-T Easy
vector (Promega), and the ligation mixes were used to transform
competent Escherichia coli DH5-α cells. Individual colonies
were screened for DNA inserts, and the DNA sequence was
determined by automated sequencing.
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